Article of footwear with maze
    1.
    发明授权
    Article of footwear with maze 有权
    迷宫鞋类文章

    公开(公告)号:US08919776B2

    公开(公告)日:2014-12-30

    申请号:US13454460

    申请日:2012-04-24

    IPC分类号: A63F9/08

    摘要: An article of footwear is provided having one or more maze units each comprising a base mounted to the upper of the footwear, a transparent cover secured about the periphery of the base defining a hollow enclosure and an array of partitions located within the enclosure forming channels along which one or more objects are movable.

    摘要翻译: 提供一种鞋类物品,其具有一个或多个迷宫单元,每个迷宫单元包括安装到鞋类的鞋面上的基座,围绕基部周边固定的透明盖,限定中空外壳,以及位于外壳内的分隔件阵列,形成通道 哪一个或多个物体是可移动的。

    ARTICLE OF FOOTWEAR WITH MAZE
    2.
    发明申请
    ARTICLE OF FOOTWEAR WITH MAZE 审中-公开
    鞋子与MAZE的文章

    公开(公告)号:US20130276334A1

    公开(公告)日:2013-10-24

    申请号:US13454460

    申请日:2012-04-24

    IPC分类号: A43B23/24

    摘要: An article of footwear is provided having one or more maze units each comprising a base mounted to the upper of the footwear, a transparent cover secured about the periphery of the base defining a hollow enclosure and an array of partitions located within the enclosure forming channels along which one or more objects are movable.

    摘要翻译: 提供一种鞋类物品,其具有一个或多个迷宫单元,每个迷宫单元包括安装到鞋类的鞋面上的基座,围绕基部周边固定的透明盖,限定中空外壳,以及位于外壳内的分隔件阵列,形成通道 哪一个或多个物体是可移动的。

    Methods and compositions based on Shiga toxin type 1 protein
    5.
    发明申请
    Methods and compositions based on Shiga toxin type 1 protein 有权
    基于志贺毒素1型蛋白的方法和组合物

    公开(公告)号:US20070292426A1

    公开(公告)日:2007-12-20

    申请号:US11788546

    申请日:2007-04-20

    摘要: The invention is based on the discovery of the epitope in the Stx1 protein for the 13C4 antibody. The invention features non-full length Stx1 polypeptides that include the epitope for the 13C4 monoclonal antibody epitope. The invention also features methods of producing anti-Stx1 antibodies specific for the 13C4 epitope of the Stx1 protein. Additionally, the invention features methods for treating a subject having, or at risk of developing, a Shiga toxin associated disease (e.g., hemolytic uremia syndrome and diseases associated with E. coli and S. dysenteriae infection) with a polypeptide that includes the 13C4 epitope or with an anti-Stx1 antibody developed using the methods of the invention. Furthermore, the invention features the detection of Stx1 in a sample using the antibodies developed using the methods of the invention.

    摘要翻译: 本发明基于用于13C4抗体的Stx1蛋白中的表位的发现。 本发明的特征是非全长Stx1多肽,其包括13C4单克隆抗体表位的表位。 本发明还具有产生对Stx1蛋白的13C4表位特异的抗Stx1抗体的方法。 另外,本发明的特征在于具有包含13C4表位的多肽或具有发展志贺毒素相关疾病(例如,溶血性尿毒症综合征和与大肠杆菌和痢疾杆菌感染相关的疾病)的受试者的方法。 或使用本发明的方法开发的抗Stx1抗体。 此外,本发明的特征在于使用使用本发明的方法开发的抗体检测样品中的Stx1。

    Methods and compositions based on shiga toxin type 2 protein
    6.
    发明授权
    Methods and compositions based on shiga toxin type 2 protein 有权
    基于志贺毒素2型蛋白的方法和组合物

    公开(公告)号:US08969529B2

    公开(公告)日:2015-03-03

    申请号:US13142556

    申请日:2010-01-21

    摘要: The invention is based on the discovery of the epitope in the Stx2 protein for the 11 E1O antibody. The invention features compositions containing non-full length Stx2 polypeptides that include the 11 E1O monoclonal antibody epitope. The invention also features methods of producing anti-Stx2 antibodies specific for the 11 E1O epitope of the Stx2 protein. Additionally, the invention features methods for treating a subject having, or at risk of developing, a Shiga toxin associated disease (e.g., hemolytic uremia syndrome and diseases associated with E. coli and S. dysenteriae infection) with a polypeptide that includes the 11 E1O epitope or with an anti-Stx2 antibody developed using the methods of the invention. Furthermore, the invention features the detection of Stx2 in a sample using the antibodies developed using the methods of the invention.

    摘要翻译: 本发明基于11 E1O抗体的Stx2蛋白中的表位的发现。 本发明的特征在于包含非全长Stx2多肽的组合物,其包括11E1O单克隆抗体表位。 本发明还具有产生对Stx2蛋白的11E1O表位特异的抗Stx2抗体的方法。 另外,本发明的特征在于用包含11个E1O的多肽治疗具有或有发展志贺毒素相关疾病(例如,溶血性尿毒症综合征和与大肠杆菌和痢疾杆菌感染相关的疾病)的受试者的方法 表位或使用本发明的方法开发的抗Stx2抗体。 此外,本发明的特征在于使用使用本发明的方法开发的抗体检测样品中的Stx2。

    Humanized monoclonal antibodies that protect against shiga toxin induced disease
    8.
    发明申请
    Humanized monoclonal antibodies that protect against shiga toxin induced disease 审中-公开
    防止志贺毒素诱发疾病的人源化单克隆抗体

    公开(公告)号:US20070003560A1

    公开(公告)日:2007-01-04

    申请号:US11471369

    申请日:2006-06-20

    摘要: The present invention describes the preparation and use of biologically and immunologically active humanized monoclonal antibodies to Shiga toxin, a toxin associated with HC and the potentially life-threatening sequela HUS transmitted by strains of pathogenic bacteria. The present invention describes how these humanized antibodies may be used in the treatment or prevention of Shiga toxin induced diseases. One aspect of the invention is the humanized monoclonal antibody which binds Shiga toxin where the constant regions are IgG1-kappa and the variable regions are murine in origin. Yet another aspect of the invention is expression vectors and host cells transformed with such vectors which express the humanized monoclonal antibodies of the present invention.

    摘要翻译: 本发明描述了生物学和免疫学活性的人源化单克隆抗体与志贺毒素(一种与HC相关的毒素)和潜在的危及生命的后遗症HUS由病原菌菌株传播的制备和应用。 本发明描述了这些人源化抗体如何用于治疗或预防志贺毒素诱导的疾病。 本发明的一个方面是结合志贺毒素的人源化单克隆抗体,其中恒定区是IgG1-κ,可变区是起源的鼠。 本发明的另一方面是用表达本发明的人源化单克隆抗体的载体转化的表达载体和宿主细胞。

    Methods and compositions based on Shiga toxin type 1 protein
    9.
    发明授权
    Methods and compositions based on Shiga toxin type 1 protein 有权
    基于志贺毒素1型蛋白的方法和组合物

    公开(公告)号:US08293245B2

    公开(公告)日:2012-10-23

    申请号:US11788546

    申请日:2007-04-20

    IPC分类号: A61K39/00

    摘要: The invention is based on the discovery of the epitope in the Stx1 protein for the 13C4 antibody. The invention features non-full length Stx1 polypeptides that include the epitope for the 13C4 monoclonal antibody epitope. The invention also features methods of producing anti-Stx1 antibodies specific for the 13C4 epitope of the Stx1 protein. Additionally, the invention features methods for treating a subject having, or at risk of developing, a Shiga toxin associated disease (e.g., hemolytic uremia syndrome and diseases associated with E. coli and S. dysenteriae infection) with a polypeptide that includes the 13C4 epitope or with an anti-Stx1 antibody developed using the methods of the invention. Furthermore, the invention features the detection of Stx1 in a sample using the antibodies developed using the methods of the invention.

    摘要翻译: 本发明基于用于13C4抗体的Stx1蛋白中的表位的发现。 本发明的特征是非全长Stx1多肽,其包括13C4单克隆抗体表位的表位。 本发明还具有产生对Stx1蛋白的13C4表位特异的抗Stx1抗体的方法。 另外,本发明的特征在于具有包含13C4表位的多肽或具有发展志贺毒素相关疾病(例如,溶血性尿毒症综合征和与大肠杆菌和痢疾杆菌感染相关的疾病)的受试者的方法。 或使用本发明的方法开发的抗Stx1抗体。 此外,本发明的特征在于使用使用本发明的方法开发的抗体检测样品中的Stx1。

    METHODS AND COMPOSITIONS BASED ON SHIGA TOXIN TYPE 2 PROTEIN
    10.
    发明申请
    METHODS AND COMPOSITIONS BASED ON SHIGA TOXIN TYPE 2 PROTEIN 有权
    基于SHIGA毒素2型蛋白的方法和组合

    公开(公告)号:US20110318357A1

    公开(公告)日:2011-12-29

    申请号:US13142556

    申请日:2010-01-21

    摘要: The invention is based on the discovery of the epitope in the Stx2 protein for the 11 E1O antibody. The invention features compositions containing non-full length Stx2 polypeptides that include the 11 E1O monoclonal antibody epitope. The invention also features methods of producing anti-Stx2 antibodies specific for the 11 E1O epitope of the Stx2 protein. Additionally, the invention features methods for treating a subject having, or at risk of developing, a Shiga toxin associated disease (e.g., hemolytic uremia syndrome and diseases associated with E. coli and S. dysenteriae infection) with a polypeptide that includes the 11 E1O epitope or with an anti-Stx2 antibody developed using the methods of the invention. Furthermore, the invention features the detection of Stx2 in a sample using the antibodies developed using the methods of the invention.

    摘要翻译: 本发明基于11 E1O抗体的Stx2蛋白中的表位的发现。 本发明的特征在于包含非全长Stx2多肽的组合物,其包括11E1O单克隆抗体表位。 本发明还具有产生对Stx2蛋白的11E1O表位特异的抗Stx2抗体的方法。 另外,本发明的特征在于用包含11个E1O的多肽治疗具有或有发展志贺毒素相关疾病(例如,溶血性尿毒症综合征和与大肠杆菌和痢疾杆菌感染相关的疾病)的受试者的方法 表位或使用本发明的方法开发的抗Stx2抗体。 此外,本发明的特征在于使用使用本发明的方法开发的抗体检测样品中的Stx2。